Follow
Paola Alberti, MD, PhD, Board in Neurology
Paola Alberti, MD, PhD, Board in Neurology
School of Medicine and Surgery, University of Milano-Bicocca
Verified email at unimib.it - Homepage
Title
Cited by
Cited by
Year
Guillain-Barré syndrome related to COVID-19 infection
P Alberti, S Beretta, M Piatti, A Karantzoulis, ML Piatti, P Santoro, ...
Neurology-Neuroimmunology Neuroinflammation 7 (4), 2020
4292020
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
G Cavaletti, DR Cornblath, ISJ Merkies, TJ Postma, E Rossi, B Frigeni, ...
Annals of Oncology 24 (2), 454-462, 2013
3392013
Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools
G Cavaletti, B Frigeni, F Lanzani, L Mattavelli, E Susani, P Alberti, ...
European journal of cancer 46 (3), 479-494, 2010
3122010
Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer
AA Argyriou, G Cavaletti, C Briani, R Velasco, J Bruna, M Campagnolo, ...
Cancer 119 (2), 438-444, 2013
2542013
Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire
M Van Leeuwen, O Husson, P Alberti, JI Arraras, OL Chinot, A Costantini, ...
Health and Quality of life Outcomes 16 (1), 1-15, 2018
2012018
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
P Alberti, E Rossi, DR Cornblath, ISJ Merkies, TJ Postma, B Frigeni, ...
Annals of oncology 25 (1), 257-264, 2014
1702014
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients
R Velasco, J Bruna, C Briani, AA Argyriou, G Cavaletti, P Alberti, B Frigeni, ...
Journal of Neurology, Neurosurgery & Psychiatry 85 (4), 392-398, 2014
1672014
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
G Cavaletti, P Alberti, P Marmiroli
The lancet oncology 12 (12), 1151-1161, 2011
1452011
Chemotherapy-induced neuropathy
G Cavaletti, P Alberti, B Frigeni, M Piatti, E Susani
Current treatment options in neurology 13, 180-190, 2011
1312011
Voltage‐gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin‐induced peripheral neurotoxicity: Results from a prospective multicenter study
AA Argyriou, G Cavaletti, A Antonacopoulou, AA Genazzani, C Briani, ...
Cancer 119 (19), 3570-3577, 2013
1302013
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
AA Argyriou, R Velasco, C Briani, G Cavaletti, J Bruna, P Alberti, ...
Annals of oncology 23 (12), 3116-3122, 2012
1212012
Efficacy of a novel sigma-1 receptor antagonist for oxaliplatin-induced neuropathy: a randomized, double-blind, placebo-controlled phase IIa clinical trial
J Bruna, S Videla, AA Argyriou, R Velasco, J Villoria, C Santos, C Nadal, ...
Neurotherapeutics 15, 178-189, 2018
1132018
Long‐term course of oxaliplatin‐induced polyneuropathy: a prospective 2‐year follow‐up study
C Briani, AA Argyriou, C Izquierdo, R Velasco, M Campagnolo, P Alberti, ...
Journal of the Peripheral Nervous System 19 (4), 299-306, 2014
1012014
Chemotherapy‐induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale
B Frigeni, M Piatti, F Lanzani, P Alberti, P Villa, C Zanna, M Ceracchi, ...
Journal of the peripheral nervous system 16 (3), 228-236, 2011
822011
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings
AA Argyriou, SB Park, B Islam, S Tamburin, R Velasco, P Alberti, J Bruna, ...
Journal of Neurology, Neurosurgery & Psychiatry 90 (12), 1361-1369, 2019
792019
Chemotherapy‐induced peripheral neurotoxicity: a multifaceted, still unsolved issue
G Cavaletti, P Alberti, AA Argyriou, M Lustberg, NP Staff, S Tamburin, ...
Journal of the Peripheral Nervous System 24, S6-S12, 2019
702019
Overview and critical revision of clinical assessment tools in chemotherapy‐induced peripheral neurotoxicity
SB Park, P Alberti, NA Kolb, JS Gewandter, A Schenone, AA Argyriou
Journal of the Peripheral Nervous System 24, S13-S25, 2019
682019
Vinca alkaloids, thalidomide and eribulin‐induced peripheral neurotoxicity: From pathogenesis to treatment
B Islam, M Lustberg, NP Staff, N Kolb, P Alberti, AA Argyriou
Journal of the Peripheral Nervous System 24, S63-S73, 2019
682019
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity
AF Leblanc, JA Sprowl, P Alberti, A Chiorazzi, WD Arnold, AA Gibson, ...
The Journal of clinical investigation 128 (2), 816-825, 2018
682018
Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery
KM Wozniak, JJ Vornov, Y Wu, Y Liu, VA Carozzi, V Rodriguez-Menendez, ...
Cancer research 78 (3), 817-829, 2018
622018
The system can't perform the operation now. Try again later.
Articles 1–20